Tempest Therapeutics

TPST · NASDAQ

$0.5762−$0.0239 (−3.98%)TodayMarket closed ·
Prev close $0.6001

Who owns TPST

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 61.1% of TPST’s shares.

  • Angel (Matthew)31.7%
  • Lotus Capital Limited21.5%
  • Sabby Management, LLC3.2%
  • Versant Ventures1.7%
  • Next 6 largest institutions3.0%
  • All other shareholders38.9%
Top institutional holders of TPST
HolderShares% of shares
Angel (Matthew)5.07M31.72%
Lotus Capital Limited3.43M21.47%
Sabby Management, LLC511.29K3.20%
Versant Ventures269.77K1.69%
Vanguard Capital Management, LLC233.89K1.46%
Geode Capital Management, L.L.C.86.63K0.54%
Vanguard Fiduciary Trust Co68.91K0.43%
BlackRock Institutional Trust Company, N.A.39.07K0.24%
Squarepoint Capital LLP30.90K0.19%
Northern Trust Investments, Inc.20.14K0.13%

Largest mutual fund holders

Top mutual fund holders of TPST
HolderShares% of shares
Vanguard Extended Market Index Fund128.94K0.81%
Vanguard Total Stock Market Index Fund104.94K0.66%
Fidelity Extended Market Index Fund48.45K0.30%
Fidelity Series Total Market Index Fund15.68K0.10%
Fidelity Total Market Index Fund7.50K0.05%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of TPST in the last 6 months.

Latest TPST insider transactions
InsiderTypeSharesValue
Smith Nancy FredaAward25.00K—
Yee John D.Award25.00K—
Richey William DrakeAward25.00K—

Short interest

Settled Sep 30, 2026

Shares short
608.43K
Days to cover
1.00
% of shares outstanding
3.81%
Average daily volume
11.20M
Change since last report
+73.6%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.